Antibody-Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care

  Рет қаралды 1,331

PeerView Oncology

PeerView Oncology

6 ай бұрын

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CE/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BUC865. CME/NCPD/CE/CPE/AAPA credit will be available until December 9, 2024.
Antibody-Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.
Disclosure Policy
All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty/Planner Disclosures
Chair/Planner
Beth Sandy, MSN, CRNP, FAPO, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc. and Janssen Pharmaceuticals, Inc.
Speakers Bureau participant with Amgen Inc.; AstraZeneca; Jazz Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; and Takeda Pharmaceutical Company Limited.
Faculty/Planner
Jamie Carroll, APRN, CNP, MSN, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sermonix Pharmaceuticals; and Talzenna.
Speakers Bureau participant with Horizon CME and OncLive.
Faculty/Planner
Elizabeth Prechtel Dunphy, DNP, RN, ANP-BC, AOCN, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Incyte.
Planning Committee and Reviewer Disclosures
Planners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Пікірлер
1❤️#thankyou #shorts
00:21
あみか部
Рет қаралды 88 МЛН
World’s Deadliest Obstacle Course!
28:25
MrBeast
Рет қаралды 128 МЛН
Increíble final 😱
00:37
Juan De Dios Pantoja 2
Рет қаралды 106 МЛН
Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA
28:55
Manage Health Foundation MHF
Рет қаралды 7 М.
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer
1:32:31
Cancer Immunotherapy Basics: Understand the science behind this cutting-edge treatment
37:26
She Hasn't Eaten in 16 Years (No Food, No Water)
21:14
Drew Binsky
Рет қаралды 1,2 МЛН
Antibody-drug Conjugates in the Clinic:
57:16
Certara
Рет қаралды 2,5 М.
Harnessing Innovation in Bladder Cancer Care
1:23:25
PeerView Oncology
Рет қаралды 177
Is Anastrozole the New Wonder Drug? - with Dr Tasha
4:44
Dr Tasha
Рет қаралды 8 М.
1❤️#thankyou #shorts
00:21
あみか部
Рет қаралды 88 МЛН